Olaparib plus /- atezolizumab in patients with BRCA-mutated (BRCAmt) locally advanced unresectable or metastatic (advanced) breast cancer: an open-label, multicenter, randomized phase II trialKristina A. Fanucci,Mary Jo Pilat,Derek Shyr,Yu Shyr,Scott A. Boerner,Diane Durecki,Anne Noonan,Vandana Abramson,Cesar Santa-Maria,Hyo Han,Rita Nanda,Elizabeth Claire Dees,Haeseong Park,Saundra Buys, Namrata Peswani,Helen Chew,Hadeel Assad,Gerburg Wulf, Angelique Richardson,Meghna S. Trivedi,Adam Brufsky,James Abbruzzese, Anosheh Afghahi,Elad Sharon,Kurt Schalper,Patricia LoRussoCANCER RESEARCH(2023)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要